103 related articles for article (PubMed ID: 7867974)
1. The protective potency of two commonly used cardioplegic solutions on cultured endothelial cells exposed to free-oxygen radicals injury.
Weigel G; Griesmacher A; Toma C; Leukauf C; Schreiner W; Wolner E
Free Radic Biol Med; 1994 Dec; 17(6):577-85. PubMed ID: 7867974
[TBL] [Abstract][Full Text] [Related]
2. Myocardial protection with Bretschneider cardioplegic solution--an evaluation of full oxygenation.
Podesser B; Wollenek G; Windischbauer A; Zegner M; Hausleithner V; Seitelberger R; Losert U; Wolner E
Eur Surg Res; 1994; 26(2):133-40. PubMed ID: 8005169
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell toxicity of solid-organ preservation solutions.
von Oppell UO; Pfeiffer S; Preiss P; Dunne T; Zilla P; Reichart B
Ann Thorac Surg; 1990 Dec; 50(6):902-10. PubMed ID: 2122822
[TBL] [Abstract][Full Text] [Related]
4. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
[TBL] [Abstract][Full Text] [Related]
5. Long-term preservation of donor hearts: the effect of intra- and extracellular-type of cardioplegic solutions on myocardial high energy phosphate content.
Dyszkiewicz W; Minten J; Flameng W
Mater Med Pol; 1990; 22(3):147-52. PubMed ID: 2132419
[TBL] [Abstract][Full Text] [Related]
6. Long-term hypothermic storage of the mammalian heart for transplantation: a comparison of three cardioplegic solutions.
Galiñanes M; Murashita T; Hearse DJ
J Heart Lung Transplant; 1992; 11(4 Pt 1):624-35. PubMed ID: 1498125
[TBL] [Abstract][Full Text] [Related]
7. The effects of two different crystalloid cardioplegic solutions on cultured human endothelial cells.
Solberg S; Larsen T; Lindal S; Prydz P; Jørgensen L; Sørlie D
J Cardiovasc Surg (Torino); 1989; 30(4):669-74. PubMed ID: 2506190
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the protective prorerties of St. Thomas', Tyers', and Bretschneider's cardioplegic solutions in the neonatal rabbit heart].
Murashita T; Yasuda K
Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2019-26. PubMed ID: 8958717
[TBL] [Abstract][Full Text] [Related]
9. Influence of oxygen radicals generating agents on eicosanoid metabolism of human endothelial cells.
Griesmacher A; Weigel G; David M; Schimke I; Mueller MM
Thromb Res; 1992 Mar; 65(6):721-31. PubMed ID: 1636164
[TBL] [Abstract][Full Text] [Related]
10. Cardioplegia and vascular injury. Dissociation of the effects of ischemia from those of the cardioplegic solution.
Saldanha C; Hearse DJ
J Thorac Cardiovasc Surg; 1994 Aug; 108(2):279-90. PubMed ID: 8041176
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the protective effect of a modified StTH solution and HTK-B on the energy and functional status of the isolated rat heart.
Chernikov VS; Tutterová M; Bakuleva NP; Vavrínková H; Kostava VT; Vrána M
Cor Vasa; 1992; 34(4):306-13. PubMed ID: 1308722
[TBL] [Abstract][Full Text] [Related]
12. Effects of H2O2 and CHPO on ATP-, CP-content and 14C-HX-uptake by HUVECS.
Griesmacher A; Weigel G; Windischbauer A; Müller MM
Adv Exp Med Biol; 1991; 309A():349-52. PubMed ID: 1789241
[No Abstract] [Full Text] [Related]
13. Biochemical and functional effects of creatine phosphate in cardioplegic solution during aortic valve surgery--a clinical study.
Thorelius J; Thelin S; Ronquist G; Halden E; Hansson HE
Thorac Cardiovasc Surg; 1992 Feb; 40(1):10-3. PubMed ID: 1631861
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of hypoxia and reoxygenation on human umbilical endothelial cells.
Windischbauer A; Griesmacher A; Müller MM
Eur J Clin Chem Clin Biochem; 1994 Apr; 32(4):279-84. PubMed ID: 8038269
[TBL] [Abstract][Full Text] [Related]
15. [Single-dose and high-volume Bretschneider cardioplegic solution for congenital heart surgery].
Asano H; Kyo S; Ogiwara M; Tsunemoto M; Yokote Y; Omoto R; Koike K; Kobayashi T; Kobayashi J; Taketazu M
Kyobu Geka; 1999 Jan; 52(1):82-6. PubMed ID: 10024809
[TBL] [Abstract][Full Text] [Related]
16. Differences in high-energy phosphate catabolism between the rat and the dog in a heart preservation model.
Minten J; Segel LD; Van Belle H; Wynants J; Flameng W
J Heart Lung Transplant; 1991; 10(1 Pt 1):71-8. PubMed ID: 1901025
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery.
Karck M; Vivi A; Tassini M; Schwalb H; Askenasy N; Navon G; Borman JB; Uretzky G
J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717
[TBL] [Abstract][Full Text] [Related]
18. In-vitro effects of cardioplegic solutions on human saphenous vein endothelium--a scanning electron microscopy study.
Macchiarelli G; Chiavarelli R; Macchiarelli AG; Chiavarelli M; Nigri G; Fabi F; Del Basso P; Motta PM; Marino B
Thorac Cardiovasc Surg; 1994 Oct; 42(5):264-70. PubMed ID: 7863487
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the solutions of Bretschneider, St. Thomas' Hospital and the National Institutes of Health for cardioplegic protection during moderate hypothermic arrest.
Kober IM; Obermayr RP; Brüll T; Ehsani N; Schneider B; Spieckermann PG
Eur Surg Res; 1998; 30(4):243-51. PubMed ID: 9704750
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia.
Ebel D; Preckel B; You A; Müllenheim J; Schlack W; Thämer V
Br J Anaesth; 2002 Jun; 88(6):828-35. PubMed ID: 12173202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
